Jennah Cutting
Family · Woodstock, GANPI 1184161622
Payments from drug & device makers
Across 415 payments — averaging $19.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vanda Pharmaceuticals Inc.$2K
- Otsuka America Pharmaceutical, Inc.$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$751
- Johnson & Johnson$748
- AbbVie$709
- Teva Pharmaceuticals USA, Inc.$398
- plus $3K from 21 others
What the payments were for
- Consulting fees$2303%
- Food & beverage$7,98096%
- Education$621%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 84 | $1,713 |
| Otsuka America Pharmaceutical, Inc. | 49 | $1,009 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 40 | $751 |
| Johnson & Johnson | 34 | $748 |
| AbbVie | 35 | $709 |
| Teva Pharmaceuticals USA, Inc. | 13 | $398 |
| Axsome Therapeutics, Inc. | 19 | $367 |
| Lundbeck LLC | 15 | $302 |
| Neos Therapeutics, LP | 16 | $283 |
| Corium, LLC | 15 | $237 |
| Janssen Scientific Affairs, LLC | 2 | $230 |
| Eisai Inc. | 16 | $193 |
| Bausch Health US, LLC | 10 | $175 |
| Neurocrine Biosciences, Inc. | 10 | $172 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $158 |
| Idorsia Pharmaceuticals US Inc | 9 | $147 |
| Alkermes, Inc. | 7 | $135 |
| Tris Pharma Inc | 8 | $118 |
| Almatica Pharma LLC | 5 | $93 |
| Supernus Pharmaceuticals, Inc. | 3 | $80 |
| Merck | 5 | $77 |
| Novo Nordisk | 4 | $60 |
| Lilly USA, LLC | 2 | $43 |
| Sage Therapeutics, LLC | 1 | $26 |
| Acadia Pharmaceuticals Inc | 1 | $18 |
| Indivior Inc. | 1 | $16 |
| Adlon Therapeutics L.p. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,272 in reported general payments places this provider in the 95th percentile of 6,258 family providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Austedo XrDeutetrabenazine | 24 | $145,770 |
| SpravatoEsketamine Hcl | 85 | $120,934 |
| RexultiBrexpiprazole | 13 | $55,375 |
| Adzenys Xr-OdtAmphetamine | 34 | $16,991 |
| VraylarCariprazine Hcl | 11 | $14,961 |
| DayvigoLemborexant | 12 | $9,588 |
| VyvanseLisdexamfetamine Dimesylate | 11 | $4,867 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 87 | $3,276 |
| Vilazodone Hcl | 30 | $2,239 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 63 | $2,115 |
| Duloxetine Hcl | 53 | $1,691 |
| Bupropion XlBupropion Hcl | 72 | $1,637 |
| Estradiol (Twice Weekly)Estradiol | 22 | $1,121 |
| Buspirone Hcl | 56 | $1,037 |
| Lamotrigine | 77 | $1,001 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Teva Pharmaceuticals USA, Inc.Austedo Xr | $398 | $145,77024 claims |
| Johnson & JohnsonSpravato | $748 | $120,93485 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $1,009 | $55,37513 claims |
| Neos Therapeutics, LPAdzenys Xr-Odt | $283 | $16,99134 claims |
| AbbVieVraylar, Armour Thyroid | $709 | $15,72522 claims |
| Eisai Inc.Dayvigo | $193 | $9,58812 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Vyvanse | $158 | $4,86711 claims |
| Almatica Pharma LLCSertraline Hcl | $93 | $29122 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 6,258 family providers in Georgia.
Other family in Woodstock
- Allie McAllisterMarietta$299K
- Tonita WashingtonLawrenceville$153K
- Erin HenryLawrenceville$135K
- Trisha RomanPeachtree City$134K
- Lori ReedMarietta$106K
- Julia BranchCumming$102K
- Hannah BanachWaycross$85K
- Morgan GroothandEvans$81K
- Anna Carolina WrightLilburn$69K
- Jessica FeehanCanton$51K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.